NCT07367581 Costotransverse Foramen Block Versus Thoracic Paravertebral Block in Thoracotomy for Lung Cancer
| NCT ID | NCT07367581 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Cancer Institute, Egypt |
| Condition | Costotransverse Foramen Block |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2026-01-24 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2026-01-24 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the costotransverse foramen block (CTFB) with thoracic paravertebral block (TPVB) in patients undergoing thoracotomy for lung cancer.
Eligibility Criteria
Inclusion Criteria: * Age \> 18 years and ≤ 65 years old. * American Society of Anesthesiologists (ASA) physical status II-III. * Body mass index 18-35 kg/m2. * Patients scheduled for thoracotomies for lung cancer. Exclusion Criteria: * Patient refusal. * History of sensitivity to local anesthetics. * History of psychological disorders. * Contraindication to regional anesthesia, e.g., local sepsis, pre-existing peripheral neuropathies, and coagulopathy. * Severe respiratory, cardiac, hepatic, or renal disease. * Morbid obesity. * Uncooperative patients. * Patients on chronic pain therapy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07367581 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Costotransverse Foramen Block. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07367581 currently recruiting?
Yes, NCT07367581 is actively recruiting participants. Contact the research team at mai.elrawas@nci.cu.edu.eg for enrollment information.
Where is the NCT07367581 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07367581 clinical trial?
NCT07367581 is sponsored by National Cancer Institute, Egypt. The trial plans to enroll 70 participants.